REGOXIDINE (FOR WOMEN)
NDC 57483-175, MINOXIDIL, aerosol, foam, from INNOVUS PHARMACEUTICALS, INC..
- Product NDC
- 57483-175
- Status
- Listed
- Labeler
- INNOVUS PHARMACEUTICALS, INC.
- Dosage form
- AEROSOL, FOAM
- Route
- TOPICAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA218616
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/57483-175 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MINOXIDIL50 mg/g
Pharmacologic classes
Arteriolar Vasodilation [PE]; Arteriolar Vasodilator [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 57483-175-11 | 57483017511 | 1 CAN in 1 CARTON (57483-175-11) / 60 g in 1 CAN (57483-175-01) |
| 57483-175-12 | 57483017512 | 2 CAN in 1 CARTON (57483-175-12) / 60 g in 1 CAN (57483-175-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 57483-175 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/57483-175 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 57483-175. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.